GSK in £1.2bn deal for sleeping pill rights
Tuesday 15 July 2008
The UK's biggest pharmaceutical group, GlaxoSmithKline, is to pay up to £1.2bn for the rights to develop and sell almorexant, an anti-insomnia treatment in its final stage of testing.
GSK will initially spend £66m to help the drug's Swiss maker, Actelion, push the sleeping pill through its phase three trials in Europe. Assuming almorexant passes the licencing requirements, Glaxo's will be liable to pay additional sums relating to sales and other applications for the treatment.
A spokesperson for the group said yesterday the deal was unlikely to result in the whole £1.2bn being paid and declined to comment on what other trials were likely for almorexant.
According to analysts at Dresdner Kleinwort, almorexant is expected to be ready for market by 2011. With 80 million sufferers in the United States alone, experts at JP Morgan Cazenove argue that the US market for insomnia treatments is worth up to $1.2bn.
GSK and Actelion have agreed to continue to pool research into insomnia treatments, although at present this does not extend beyond almorexant.
Analysts covering GSK had one eye on the group's interim results, due next week. It will be one of the first chances the group's chief executive, Andrew Witty, has had to talk directly to shareholders who have seen the stock fall steadily over the past 12 months.
Jeremy Batstone-Carr, an analyst at Charles Stanley, reckons that Mr Witty will take the opportunity to outline his strategy, two months into the job.
- 1 President of Argentina adopts Jewish godson to 'stop him turning into a werewolf'
- 2 Doctors remove 80 teeth from boy's jaw
- 3 The 'Black Museum': After 150 years, public set to see exhibits from police’s grisly crime museum
- 4 Stoke-on-Trent becomes first British city to be classified as 'disaster resilient' by the United Nations
- 5 Sir Winston Churchill’s family begged him not to convert to Islam, letter reveals
President of Argentina adopts Jewish godson to 'stop him turning into a werewolf'
The 'Black Museum': After 150 years, public set to see exhibits from police’s grisly crime museum
Downfall of Dustin 'Screech' Diamond, the 'Saved By The Bell' star charged with bar stabbing
Syrian teenager Usaid Barho reveals how he escaped from Isis using a suicide vest
Sir Winston Churchill’s family begged him not to convert to Islam, letter reveals
Millions of Britons struggling to feed themselves and facing malnourishment
British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
Ukip member gets into Christmas spirit with Union Flag plea to Santa 'for our country back'
Germany anti-Islam protests: 17,000 march on Dresden against 'Islamification of the West'
Nigel Farage: Ukip leader named 'Briton of the year' by The Times
Immigrants make UK racist, says Ukip councillor Trevor Shonk
iJobs Money & Business
Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...
Not specified: Selby Jennings: Quantitative Research | Global Equity | New Yor...
Not specified: Selby Jennings: SVP Model Validation This top tiered investment...
Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...